Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 52

1.

Successful cure of daptomycin-non-susceptible, vancomycin-intermediate Staphylococcus aureus prosthetic aortic valve endocarditis directed by synergistic in vitro time-kill study.

Sumon ZE, Berenson CS, Sellick JA, Bulman ZP, Tsuji BT, Mergenhagen KA.

Infect Dis (Lond). 2019 Apr;51(4):287-292. doi: 10.1080/23744235.2018.1533646. Epub 2019 Feb 14.

PMID:
30760062
2.

Sialic Acid-Dependent Inhibition of T Cells by Exosomal Ganglioside GD3 in Ovarian Tumor Microenvironments.

Shenoy GN, Loyall J, Berenson CS, Kelleher RJ Jr, Iyer V, Balu-Iyer SV, Odunsi K, Bankert RB.

J Immunol. 2018 Dec 15;201(12):3750-3758. doi: 10.4049/jimmunol.1801041. Epub 2018 Nov 16.

PMID:
30446565
3.

Successful treatment of multidrug-resistant Pseudomonas aeruginosa pubic symphysis osteomyelitis with ceftolozane/tazobactam.

Kurtzhalts KE, Mergenhagen KA, Manohar A, Berenson CS.

BMJ Case Rep. 2017 Mar 31;2017. pii: bcr2016217005. doi: 10.1136/bcr-2016-217005.

4.

Correction: Lack of Effect of Oral Sulforaphane Administration on Nrf2 Expression in COPD: A Randomized, Double-Blind, Placebo Controlled Trial.

Wise RA, Holbrook JT, Criner G, Sethi S, Rayapudi S, Sudini KR, Sugar EA, Burke A, Thimmulappa R, Singh A, Talalay P, Fahey JW, Berenson CS, Jacobs MR, Biswal S; Broccoli Sprout Extract Trial Research Group.

PLoS One. 2017 Mar 28;12(3):e0175077. doi: 10.1371/journal.pone.0175077. eCollection 2017.

5.

Lack of Effect of Oral Sulforaphane Administration on Nrf2 Expression in COPD: A Randomized, Double-Blind, Placebo Controlled Trial.

Wise RA, Holbrook JT, Criner G, Sethi S, Rayapudi S, Sudini KR, Sugar EA, Burke A, Thimmulappa R, Singh A, Talalay P, Fahey JW, Berenson CS, Jacobs MR, Biswal S; Broccoli Sprout Extract Trial Research Group.

PLoS One. 2016 Nov 10;11(11):e0163716. doi: 10.1371/journal.pone.0163716. eCollection 2016. Erratum in: PLoS One. 2017 Mar 28;12 (3):e0175077.

6.

Native valve Proteus mirabilis endocarditis: successful treatment of a rare entity formulated by in vitro synergy antibiotic testing.

Brotzki CR, Mergenhagen KA, Bulman ZP, Tsuji BT, Berenson CS.

BMJ Case Rep. 2016 Oct 20;2016. pii: bcr2016215956. doi: 10.1136/bcr-2016-215956.

7.

Burkholderia ginsengisoli bacteraemia: emergence of a novel pathogen.

Marks LR, Dodd H, Russo TA, Berenson CS.

BMJ Case Rep. 2016 Feb 24;2016. pii: bcr2015213584. doi: 10.1136/bcr-2015-213584.

8.

The Impact of Exogenous Factors on Respiratory Pathogen-Induced Innate Alveolar Macrophage Responses in COPD.

Berenson CS, Kruzel RL, Sethi S.

Immunol Invest. 2016;45(2):130-47. doi: 10.3109/08820139.2015.1113427. Epub 2016 Feb 6.

PMID:
26853802
9.

Impaired Innate COPD Alveolar Macrophage Responses and Toll-Like Receptor-9 Polymorphisms.

Berenson CS, Kruzel RL, Wrona CT, Mammen MJ, Sethi S.

PLoS One. 2015 Sep 11;10(9):e0134209. doi: 10.1371/journal.pone.0134209. eCollection 2015.

10.

Extracellular Vesicles Present in Human Ovarian Tumor Microenvironments Induce a Phosphatidylserine-Dependent Arrest in the T-cell Signaling Cascade.

Kelleher RJ Jr, Balu-Iyer S, Loyall J, Sacca AJ, Shenoy GN, Peng P, Iyer V, Fathallah AM, Berenson CS, Wallace PK, Tario J, Odunsi K, Bankert RB.

Cancer Immunol Res. 2015 Nov;3(11):1269-78. doi: 10.1158/2326-6066.CIR-15-0086. Epub 2015 Jun 25.

11.

Impaired innate immune alveolar macrophage response and the predilection for COPD exacerbations.

Berenson CS, Kruzel RL, Eberhardt E, Dolnick R, Minderman H, Wallace PK, Sethi S.

Thorax. 2014 Sep;69(9):811-8. doi: 10.1136/thoraxjnl-2013-203669. Epub 2014 Mar 31.

PMID:
24686454
12.

Non-typeable Haemophilus influenzae infective endocarditis in a renal transplant recipient: compromised host or virulent strain?

Bertelle-Ibrahim LA, Murphy TF, Kirkham C, Parameswaran GI, Berenson CS.

BMJ Case Rep. 2013 Sep 2;2013. pii: bcr2013200377. doi: 10.1136/bcr-2013-200377.

13.

Phagocytic dysfunction of human alveolar macrophages and severity of chronic obstructive pulmonary disease.

Berenson CS, Kruzel RL, Eberhardt E, Sethi S.

J Infect Dis. 2013 Dec 15;208(12):2036-45. doi: 10.1093/infdis/jit400. Epub 2013 Aug 1.

14.

Pseudomonas aeruginosa intrapetrous internal carotid artery mycotic aneurysm--a complication of mastoiditis: first reported case.

Shon AS, Berenson CS.

BMJ Case Rep. 2013 Jul 9;2013. pii: bcr2013200005. doi: 10.1136/bcr-2013-200005.

15.

Ganglioside-binding specificities of E. coli enterotoxin LT-IIc: Importance of long-chain fatty acyl ceramide.

Berenson CS, Nawar HF, Kruzel RL, Mandell LM, Connell TD.

Glycobiology. 2013 Jan;23(1):23-31. doi: 10.1093/glycob/cws123. Epub 2012 Aug 22.

16.

Binding to gangliosides containing N-acetylneuraminic acid is sufficient to mediate the immunomodulatory properties of the nontoxic mucosal adjuvant LT-IIb(T13I).

Nawar HF, Berenson CS, Hajishengallis G, Takematsu H, Mandell L, Clare RL, Connell TD.

Clin Vaccine Immunol. 2010 Jun;17(6):969-78. doi: 10.1128/CVI.00076-10. Epub 2010 Apr 14.

17.

Mammalian cell ganglioside-binding specificities of E. coli enterotoxins LT-IIb and variant LT-IIb(T13I).

Berenson CS, Nawar HF, Yohe HC, Castle SA, Ashline DJ, Reinhold VN, Hajishengallis G, Connell TD.

Glycobiology. 2010 Jan;20(1):41-54. doi: 10.1093/glycob/cwp141. Epub 2009 Sep 12.

18.
19.

Impaired phagocytosis of nontypeable Haemophilus influenzae by human alveolar macrophages in chronic obstructive pulmonary disease.

Berenson CS, Garlipp MA, Grove LJ, Maloney J, Sethi S.

J Infect Dis. 2006 Nov 15;194(10):1375-84. Epub 2006 Oct 16.

PMID:
17054066
20.

Impaired alveolar macrophage response to Haemophilus antigens in chronic obstructive lung disease.

Berenson CS, Wrona CT, Grove LJ, Maloney J, Garlipp MA, Wallace PK, Stewart CC, Sethi S.

Am J Respir Crit Care Med. 2006 Jul 1;174(1):31-40. Epub 2006 Mar 30.

21.

Inhibition of atazanavir oral absorption by lansoprazole gastric acid suppression in healthy volunteers.

Tomilo DL, Smith PF, Ogundele AB, Difrancesco R, Berenson CS, Eberhardt E, Bednarczyk E, Morse GD.

Pharmacotherapy. 2006 Mar;26(3):341-6.

PMID:
16503713
22.

Airway inflammation and bronchial bacterial colonization in chronic obstructive pulmonary disease.

Sethi S, Maloney J, Grove L, Wrona C, Berenson CS.

Am J Respir Crit Care Med. 2006 May 1;173(9):991-8. Epub 2006 Feb 10.

23.

Nontypeable Haemophilus influenzae-binding gangliosides of human respiratory (HEp-2) cells have a requisite lacto/neolacto core structure.

Berenson CS, Sayles KB, Huang J, Reinhold VN, Garlipp MA, Yohe HC.

FEMS Immunol Med Microbiol. 2005 Aug 1;45(2):171-82. Epub 2005 Apr 13.

24.
25.

The influence of St. John's wort on the pharmacokinetics and protein binding of imatinib mesylate.

Smith P, Bullock JM, Booker BM, Haas CE, Berenson CS, Jusko WJ.

Pharmacotherapy. 2004 Nov;24(11):1508-14. Erratum in: Pharmacotherapy. 2004 Dec;24(12):1837.

PMID:
15537555
26.

Effect of tenofovir disoproxil fumarate on the pharmacokinetics and pharmacodynamics of total, R-, and S-methadone.

Smith PF, Kearney BP, Liaw S, Cloen D, Bullock JM, Haas CE, Yale K, Booker BM, Berenson CS, Coakley DF, Flaherty JF.

Pharmacotherapy. 2004 Aug;24(8):970-7.

PMID:
15338845
27.

Induction of imatinib metabolism by hypericum perforatum.

Smith PF, Bullock JM, Booker BM, Haas CE, Berenson CS, Jusko WJ.

Blood. 2004 Aug 15;104(4):1229-30. No abstract available.

28.

The effects of once-daily saquinavir/minidose ritonavir on the pharmacokinetics of methadone.

Shelton MJ, Cloen D, DiFrancesco R, Berenson CS, Esch A, de Caprariis PJ, Palic B, Schur JL, Buggé CJ, Ljungqvist A, Espinosa O, Hewitt RG.

J Clin Pharmacol. 2004 Mar;44(3):293-304.

PMID:
14973306
29.

Effects of didanosine formulations on the pharmacokinetics of amprenavir.

Shelton MJ, Giovanniello AA, Cloen D, Berenson CS, Keil K, DiFrancesco R, Hewitt RG.

Pharmacotherapy. 2003 Jul;23(7):835-42.

PMID:
12885096
30.

The role of ceramide of human macrophage gangliosides in activation of human macrophages.

Berenson CS, Gallery MA, Smigiera JM, Rasp RH.

J Leukoc Biol. 2002 Sep;72(3):492-502.

PMID:
12223517
31.

The major gangliosides of human peripheral blood monocytes/macrophages: absence of ganglio series structures.

Yohe HC, Wallace PK, Berenson CS, Ye S, Reinhold BB, Reinhold VN.

Glycobiology. 2001 Oct;11(10):831-41.

PMID:
11588159
32.

Suppression of a sialyltransferase by antisense DNA reduces invasiveness of human colon cancer cells in vitro.

Zhu Y, Srivatana U, Ullah A, Gagneja H, Berenson CS, Lance P.

Biochim Biophys Acta. 2001 May 31;1536(2-3):148-60.

33.

Differences in splenic B-lymphocyte ganglioside expression and accessibility in normal and endotoxin-hyporesponsive mice.

Berenson CS, Rasp RH, Gau JT, Ryan JL, Yohe HC.

J Leukoc Biol. 2001 Jun;69(6):969-76.

PMID:
11404384
34.

Idiosyncratic rifabutin-induced leukopenia and SIADH: case report and review.

Chitre MM, Berenson CS.

Pharmacotherapy. 2001 Apr;21(4):493-7.

PMID:
11310523
35.

Gangliosides of monocyte-derived macrophages of adults with advanced HIV infection show reduced surface accessibility.

Berenson CS, Gallery MA, Katari MS, Foster EW, Pattoli MA.

J Leukoc Biol. 1998 Sep;64(3):311-21.

PMID:
9738657
36.

Human thyroid fibroblasts exhibit a distinctive phenotype in culture: characteristic ganglioside profile and functional CD40 expression.

Smith TJ, Sempowski GD, Berenson CS, Cao HJ, Wang HS, Phipps RP.

Endocrinology. 1997 Dec;138(12):5576-88.

PMID:
9389546
37.

Specific binding of Haemophilus influenzae to minor gangliosides of human respiratory epithelial cells.

Fakih MG, Murphy TF, Pattoli MA, Berenson CS.

Infect Immun. 1997 May;65(5):1695-700.

38.

A monoclonal antibody to human macrophage gangliosides inhibits macrophage migration.

Berenson CS, Patterson MA, Pattoli MA, Murphy TF.

J Leukoc Biol. 1996 Mar;59(3):371-9.

PMID:
8604015
39.

Human orbital fibroblasts in culture express ganglioside profiles distinct from those in dermal fibroblasts.

Berenson CS, Smith TJ.

J Clin Endocrinol Metab. 1995 Sep;80(9):2668-74.

PMID:
7673410
40.

n-Butyrate mediation of ganglioside expression of human and murine cancer cells demonstrates relative cell specificity.

Berenson CS, Patterson MA, Miqdadi JA, Lance P.

Clin Sci (Lond). 1995 Apr;88(4):491-9.

PMID:
7789051
41.

Determinants of differential liver-colonizing potential of variants of the MCA-38 murine colon cancer cell line.

Piscatelli JJ, Cohen SA, Berenson CS, Lance P.

Clin Exp Metastasis. 1995 Mar;13(2):141-50.

PMID:
7882616
42.

First reported case of Aspergillus granulosus infection in a cardiac transplant patient.

Fakih MG, Barden GE, Oakes CA, Berenson CS.

J Clin Microbiol. 1995 Feb;33(2):471-3.

43.

n-butyrate reduces the expression of beta-galactoside alpha 2,6-sialyltransferase in Hep G2 cells.

Shah S, Lance P, Smith TJ, Berenson CS, Cohen SA, Horvath PJ, Lau JT, Baumann H.

J Biol Chem. 1992 May 25;267(15):10652-8.

44.

Murine peritoneal macrophage gangliosides inhibit lymphocyte proliferation.

Berenson CS, Ryan JL.

J Leukoc Biol. 1991 Oct;50(4):393-401.

PMID:
1919364
45.

Altered B-lymphocyte membrane architecture indicated by ganglioside accessibility in C3H/HeJ mice.

Yohe HC, Berenson CS, Cuny CL, Ryan JL.

Infect Immun. 1990 Sep;58(9):2888-94.

46.
47.

Factors mediating lipopolysaccharide-induced ganglioside expression in murine peritoneal macrophages.

Berenson CS, Yohe HC, Ryan JL.

J Leukoc Biol. 1989 Mar;45(3):221-30.

PMID:
2494280
48.

Comparison of thymocyte and T lymphocyte gangliosides from C3H/HeN and C3H/HeJ mice.

Yohe HC, Cuny CL, Berenson CS, Ryan JL.

J Leukoc Biol. 1988 Dec;44(6):521-8.

PMID:
3264007
49.

Haemophilus aphrophilus sternal osteomyelitis.

Berenson CS, Mangi RJ.

South Med J. 1988 Dec;81(12):1593-4.

PMID:
3201307
50.

Fever, petechiae, and pulmonary infiltrates in an immunocompromised Peruvian man.

Berenson CS, Dobuler KJ, Bia FJ.

Yale J Biol Med. 1987 Sep-Oct;60(5):437-45.

Supplemental Content

Loading ...
Support Center